Establishment of a relationship between blastomere geometry and YAP localisation during compaction.


Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
09 10 2020
Historique:
received: 28 02 2020
accepted: 07 09 2020
pubmed: 16 9 2020
medline: 10 4 2021
entrez: 15 9 2020
Statut: epublish

Résumé

Precise patterning within the three-dimensional context of tissues, organs and embryos implies that cells can sense their relative position. During preimplantation development, outside and inside cells rely on apicobasal polarity and the Hippo pathway to choose their fate. Despite recent findings suggesting that mechanosensing might be central to this process, the relationship between blastomere geometry (i.e. shape and position) and the Hippo pathway effector YAP remains unknown. We used a highly quantitative approach to analyse information on the geometry and YAP localisation of individual blastomeres of mouse and human embryos. We identified the proportion of exposed cell surface area as most closely correlating with the nuclear localisation of YAP. To test this relationship, we developed several hydrogel-based approaches to alter blastomere geometry in cultured embryos. Unbiased clustering analyses of blastomeres from such embryos revealed that this relationship emerged during compaction. Our results therefore pinpoint the time during early embryogenesis when cells acquire the ability to sense changes in geometry and provide a new framework for how cells might integrate signals from different membrane domains to assess their relative position within the embryo.

Identifiants

pubmed: 32928909
pii: dev.189449
doi: 10.1242/dev.189449
pmc: PMC7561472
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J014427/1
Pays : United Kingdom
Organisme : Wellcome
ID : 103788/Z/14/Z

Informations de copyright

© 2020. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

J Cell Sci. 2005 Feb 1;118(Pt 3):505-15
pubmed: 15657073
PLoS Genet. 2014 Oct 23;10(10):e1004618
pubmed: 25340657
Cell. 2018 Apr 19;173(3):776-791.e17
pubmed: 29576449
Development. 2014 Jun;141(11):2279-88
pubmed: 24866117
Nature. 1975 Mar 20;254(5497):199-202
pubmed: 1113884
Mol Syst Biol. 2013 Dec 22;9:713
pubmed: 24366813
J Cell Sci. 2009 Jul 15;122(Pt 14):2360-70
pubmed: 19531586
Sci Signal. 2013 Nov 19;6(302):rs15
pubmed: 24255178
Philos Trans R Soc Lond B Biol Sci. 2020 Oct 12;375(1809):20190560
pubmed: 32829691
Dev Cell. 2009 Mar;16(3):398-410
pubmed: 19289085
J Cell Biol. 1977 Jul;74(1):153-67
pubmed: 873999
Development. 2015 Dec 1;142(23):3996-4009
pubmed: 26628090
Nat Cell Biol. 2015 Jul;17(7):849-55
pubmed: 26075357
Nature. 2016 Aug 18;536(7616):344-348
pubmed: 27487217
Curr Top Dev Biol. 2016;117:597-608
pubmed: 26970003
Cell. 2013 Aug 29;154(5):1047-1059
pubmed: 23954413
Development. 2017 Dec 15;144(24):4522-4529
pubmed: 29084802
Curr Protoc Cell Biol. 2010 Jun;Chapter 10:Unit 10.16
pubmed: 20521229
Dev Growth Differ. 2015 Oct;57(8):544-56
pubmed: 26450797
Development. 2011 Sep;138(18):3907-14
pubmed: 21831922
Dev Growth Differ. 2017 Jan;59(1):12-20
pubmed: 28035666
Mol Cell Proteomics. 2014 Jan;13(1):119-31
pubmed: 24126142
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
Dev Cell. 2018 Jun 18;45(6):667-679
pubmed: 29920273
Tissue Barriers. 2014 Jan 1;2(1):e28127
pubmed: 24843842
Dev Biol. 1996 Aug 1;177(2):568-79
pubmed: 8806832
Curr Biol. 2013 Jul 8;23(13):1195-201
pubmed: 23791728
Development. 2014 Jul;141(14):2813-24
pubmed: 24948601
J Cell Sci. 2009 Jul 15;122(Pt 14):2351-9
pubmed: 19531584
Nat Rev Mol Cell Biol. 2012 Sep;13(9):591-600
pubmed: 22895435
Cell. 1980 Oct;21(3):935-42
pubmed: 7438209
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10375-10380
pubmed: 30232257
Curr Biol. 2013 Jul 8;23(13):1181-94
pubmed: 23791731
Mech Dev. 2008 Mar-Apr;125(3-4):270-83
pubmed: 18083014
Dev Biol. 2013 Mar 1;375(1):13-22
pubmed: 23313818
Dev Biol. 2005 Jun 15;282(2):307-19
pubmed: 15950600
Dev Cell. 2015 Aug 24;34(4):435-47
pubmed: 26279486
Nat Commun. 2017 Oct 13;8(1):921
pubmed: 29030553

Auteurs

Christophe Royer (C)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK christophe.royer@dpag.ox.ac.uk shankar.srinivas@dpag.ox.ac.uk.

Karolis Leonavicius (K)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK.

Annemarie Kip (A)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK.

Deborah Fortin (D)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK.

Kirtirupa Nandi (K)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK.

Anna Vincent (A)

Oxford Fertility, Institute of Reproductive Sciences, Oxford OX4 2HW, UK.

Celine Jones (C)

Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.

Tim Child (T)

Oxford Fertility, Institute of Reproductive Sciences, Oxford OX4 2HW, UK.
Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.

Kevin Coward (K)

Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.

Chris Graham (C)

Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.

Shankar Srinivas (S)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK christophe.royer@dpag.ox.ac.uk shankar.srinivas@dpag.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH